Disease Management

GLP-1 Drugs Responsible for Over Ten Percent of Annual Claims 

Rebecca Plier
 

New Survey Data Reveals Rise of GLP-1 Drug Claims, With Utilization Management and Eligibility Requirements as Leading Cost-Control Mechanisms   A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer coverage and claims representation surrounding glucagon-like peptide-1 […]

Using AI to Empower Women’s Health

Amanda Wilke, CEBS
 

Many women’s underlying health conditions often go under- or undiagnosed. When present, common women’s gynecologic conditions, such as endometriosis, cause unnecessary suffering, limit women’s roles at home, and lead to economic and workplace challenges. Artificial intelligence (AI) has the power to help […]

Multiemployer Plan and Public Employer Coverage of GLP-1 Drugs

Cara McMullin
 

New Survey Data Reveals Total Reported Annual Claim Representation for GLP-1 Drugs for Weight Loss Is Almost Ten Percent A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer and plan sponsor coverage surrounding glucagon-like peptide-1 […]